Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 26.18% is 86% above its 5-year average of 14.08%, near the high end of its 5-year range (6.83%–26.18%).
As of the fiscal period ended Tuesday, March 31, 2026. 13.89% above its 12-month average of 22.98%.
Reported quarterly debt to assets ratio; no daily interpolation.
DEBT TO ASSETS RATIO
26.18%
DEBT TO ASSETS RATIO AVG TTM
22.98%
DEBT TO ASSETS RATIO AVG 3Y
16.35%
DEBT TO ASSETS RATIO AVG 5Y
14.08%
DEBT TO ASSETS RATIO AVG 10Y
8.14%
DEBT TO ASSETS RATIO AVG 15Y
4.59%
DEBT TO ASSETS RATIO AVG 20Y
3.92%
CURRENT VS TTM AVG
+13.89%
CURRENT VS 3Y AVG
+60.09%
CURRENT VS 5Y AVG
+85.95%
CURRENT VS 10Y AVG
+221.49%
CURRENT VS 15Y AVG
+469.70%
CURRENT VS 20Y AVG
+567.86%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+8926.23%
vs the sector median at left
Novo Nordisk A/S
Market Cap
$209.19B
Debt to Assets Ratio
26.18%
TTM Avg
22.98%
3Y Avg
16.35%
5Y Avg
14.08%
Market Cap
$213.42B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$161.66B
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$133.37B
Debt to Assets Ratio
0.52%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novo Nordisk A/S (NVO) | $209.19B | 26.18% | 22.98% | 16.35% | 14.08% |
| Amgen Inc. (AMGN)vs › | $207.87B | 0.60% | N/A | N/A | N/A |
| Thermo Fisher Scientific Inc. (TMO)vs › | $213.42B | 0.37% | N/A | N/A | N/A |
| Abbott Laboratories (ABT)vs › | $182.90B | 0.17% | N/A | N/A | N/A |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 0.42% | N/A | N/A | N/A |
| Pfizer Inc. (PFE)vs › | $142.54B | 0.32% | N/A | N/A | N/A |
| Danaher Corporation (DHR)vs › | $137.13B | 0.22% | N/A | N/A | N/A |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 0.52% | N/A | N/A | N/A |
| CVS Health Corp. (CVS)vs › | $133.25B | 0.36% | N/A | N/A | N/A |
| AstraZeneca PLC (AZN)vs › | $131.47B | 0.26% | N/A | N/A | N/A |
Debt/Assets
26.2%
Debt/Equity
0.67
Current Ratio
0.80
Interest Coverage
30.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 26.18% |
| 2025-12-31 | 24.12% |
| 2025-09-30 | 19.76% |
| 2025-06-30 | 20.59% |
| 2025-03-31 | 24.27% |
| 2024-12-31 | 22.07% |
| 2024-09-30 | 14.33% |
| 2024-06-30 | 15.45% |
| 2024-03-31 | 9.01% |
| 2023-12-31 | 8.59% |
| 2023-09-30 | 8.84% |
| 2023-06-30 | 9.16% |
| 2023-03-31 | 10.21% |
| 2022-12-31 | 10.69% |
| 2022-09-30 | 10.69% |
| 2022-06-30 | 11.62% |
| 2022-03-31 | 12.93% |
| 2021-12-31 | 13.70% |
| 2021-09-30 | 7.90% |
| 2021-06-30 | 8.71% |
| 2021-03-31 | 6.83% |
| 2020-12-31 | 7.15% |
| 2020-09-30 | 2.93% |
| 2020-06-30 | 3.04% |
| 2020-03-31 | 3.26% |
| 2019-12-31 | 3.57% |
| 2019-09-30 | 3.48% |
| 2019-06-30 | 3.59% |
| 2019-03-31 | 3.92% |
| 2018-12-31 | 0.46% |
| 2018-09-30 | 0.33% |
| 2018-06-30 | 0.24% |
| 2018-03-31 | 0.24% |
| 2017-12-31 | 1.66% |
| 2017-09-30 | 0.27% |
| 2017-06-30 | 1.72% |
| 2017-03-31 | 0.65% |
| 2016-12-31 | 0.23% |
| 2016-09-30 | 0.52% |
| 2016-06-30 | 0.46% |
| 2016-03-31 | 0.49% |
| 2015-12-31 | 1.17% |
| 2015-09-30 | 0.74% |
| 2015-06-30 | 0.91% |
| 2015-03-31 | 0.77% |
| 2014-12-31 | 0.93% |
| 2014-09-30 | 0.40% |
| 2014-06-30 | 0.64% |
| 2014-03-31 | 1.27% |
| 2013-12-31 | 0.31% |
| 2013-09-30 | 0.98% |
| 2013-06-30 | 1.11% |
| 2013-03-31 | 0.48% |
| 2012-12-31 | 0.76% |
| 2012-09-30 | 1.64% |
| 2012-06-30 | 1.46% |
| 2012-03-31 | 1.46% |
| 2011-12-31 | 1.32% |
| 2011-09-30 | 3.54% |
| 2011-06-30 | 2.26% |
| 2011-03-31 | 2.56% |
| 2010-12-31 | 3.62% |
| 2010-09-30 | 3.49% |
| 2010-06-30 | 7.51% |
| 2010-03-31 | 3.70% |
| 2009-12-31 | 2.54% |
| 2009-09-30 | 2.27% |
| 2009-06-30 | 2.79% |
| 2009-03-31 | 4.90% |
| 2008-12-31 | 4.58% |
| 2008-09-30 | 3.63% |
| 2008-06-30 | 2.87% |
| 2008-03-31 | 3.26% |
| 2007-12-31 | 2.86% |
| 2007-09-30 | 2.65% |
| 2007-06-30 | 2.61% |
| 2007-03-31 | 3.06% |
| 2006-12-31 | 3.39% |
| 2006-09-30 | 3.39% |
| 2006-06-30 | 3.49% |
| 2006-03-31 | 5.80% |
| 2005-12-31 | 6.42% |
| 2005-09-30 | 5.30% |
| 2005-06-30 | 4.95% |
| 2005-03-31 | 4.58% |
| 2004-12-31 | 4.53% |
| 2004-09-30 | 3.33% |
| 2004-06-30 | 3.54% |
| 2004-03-31 | 4.64% |
| 2003-12-31 | 5.02% |
| 2002-12-31 | 4.41% |
| 2001-12-31 | 5.85% |
| 2000-12-31 | 7.17% |
| 1999-12-31 | 15.72% |
| 1998-12-31 | 10.09% |
| 1997-12-31 | 12.08% |
